TY  - GEN
AU  - Nicholson,S
AU  - Guile,K
AU  - John,J
AU  - Clarke,I A
AU  - Diffley,J
AU  - Donnellan,P
AU  - Michael,A
AU  - Szlosarek,P
AU  - Dalgleish,A G
TI  - A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 in the treatment of metastatic malignant melanoma
SN  - 0960-8931
PY  - 2003///1125
KW  - Adjuvants, Immunologic
KW  - administration & dosage
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bacterial Vaccines
KW  - Disease-Free Survival
KW  - Humans
KW  - Immunotherapy
KW  - methods
KW  - Interleukin-2
KW  - Melanoma
KW  - secondary
KW  - Middle Aged
KW  - Mycobacterium
KW  - immunology
KW  - Skin Neoplasms
KW  - therapy
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Evaluation Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1097/00008390-200308000-00008
ER  -